+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Enteral), by Product (Pills, Powder), by Application, by Sales Channel (Online, Institutional, Retail), and Segment Forecasts, 2020 - 2027

  • ID: 4761216
  • Report
  • February 2020
  • Region: Global
  • 150 pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • Danone
  • Fresenius Kabi Ag
  • Nestlé
The global medical foods market size is expected to reach USD 30.4 billion by 2027, registering a CAGR of 6.3% over the forecast period. This market is driven by rising geriatric population, increasing prevalence of chronic diseases, and growing focus of policymakers on the management of malnutrition. Dietary management of chronic diseases and rare disorders is the emerging focus area for manufacturers of medical foods, which is also positively impacting the market growth. Patients with chronic diseases develop nutritional deficiencies owing to adverse effects of the disease or the drugs that are used for treatment. Medical foods address these nutritional deficiencies, further driving their consumption.

Moreover, rising prevalence of chronic diseases requiring nutritional management of patients is a key factor which is expected to drive the market growth. According to WHO Noncommunicable Diseases Progress Monitor (2017), chronic diseases such as cancer, diabetes, and cardiovascular diseases are among the leading causes of death globally, accounting for nearly 70.0% of the deaths worldwide. According to Milken Institute, the economic burden of chronic diseases in the U.S. was estimated to be USD 1.1 trillion in 2016. A constant rise has been observed in the prevalence of chronic diseases such as Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), osteoporosis, osteoarthritis, and central nervous system disorders, which require clinical dietary management. Medical foods, also known as foods for special medical purposes, are intended for the dietary management of patients with impaired or limited capacity to digest, ingest, absorb, and metabolize a normal diet and for patients with special nutrient requirements.

Diabetic neuropathy emerged as the largest application segment in 2019 owing to the increase in prevalence of diabetes and rise in the number of patients that are at risk of developing some level of neuropathy. Various initiatives are being undertaken for dietary management of diabetes and are among the key market drivers. However, the chronic kidney diseases segment is expected to witness the highest growth rate over the forecast period.

Further key findings from the report suggest:
  • Orally administered medical foods held the largest share in 2019 due to ease in administration along with high commercial availability
  • Diabetic neuropathy emerged as the leading application segment in 2019, however, chronic kidney disorder is expected to register the highest growth rate over the forecast period owing to the rising prevalence of chronic diseases such as cardiovascular diseases and cancer
  • Asia Pacific dominated the global market in 2019 due to the presence of several target diseases cases such as obesity and malnutrition in the region
  • Key players operating in the medical foods market include Danone S.A., Abbott Laboratories, Nestle S.A., Mead Johnsons & Company, LLC, and Fresenius Kabi.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Danone
  • Fresenius Kabi Ag
  • Nestlé
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Medical Foods Snapshot

Chapter 3 Global Medical Foods Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2. Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer behavior analysis
3.4.2 Market influencer analysis
3.5 Technology Outlook
3.5.1 Technology timeline
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards and compliances
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.2 Market restraint analysis
3.7.3. Industry Challenges
3.8 Medical Foods Market Analysis Tools
3.8.1. Industry analysis - Porter’s
3.8.1.1 Supplier power
3.8.1.2 Buyer power
3.8.1.3 Substitution threat
3.8.1.4 Threat from new entrant
3.8.1.5 Competitive rivalry
3.8.2. PESTEL analysis
3.8.2.1 Political landscape
3.8.2.2 Environmental landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal landscape
3.8.2.6 Economic landscape
3.8.3 Major deals & strategic alliances analysis
3.8.3.1 Mergers & acquisitions
3.8.3.2 Licensing & partnership
3.8.4 Market entry strategies

Chapter 4 Medical Foods Market-Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Competition Categorization
4.3 Vendor Landscape
4.3.1 List of Key Distributors and Channel Partners
4.3.2 Key Company Market Share Analysis, 2018/2019
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Ranking, by Region
4.5 Private Companies
4.5.1 Regional Network Map
4.5.2 Company Market Position Analysis

Chapter 5 Medical Foods Market: Route of Administration Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Medical Foods Market: Route of Administration Market Share Analysis, 2019 and 2027
5.3 Oral
5.3.1 Oral market estimates and forecasts, 2016 - 2027 (USD million)
5.4 Enteral
5.4.1 Enteral market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 6 Medical Foods Market: Product Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Global Medical Foods Market: Product Market Share Analysis, 2019 and 2027
6.3 Pills
6.3.1 Pills market estimates and forecasts, 2016 - 2027 (USD million)
6.4 Powder
6.4.1 Powder market estimates and forecasts, 2016 - 2027 (USD million)
6.5 Others
6.5.1 Others market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 7 Medical Foods Market: Application Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Global Medical Foods Market: Application Market Share Analysis, 2019 and 2027
7.3 Chronic kidney diseases
7.3.1 Chronic kidney diseases market estimates and forecasts, 2016 - 2027 (USD million)
7.4 Minimal hepatic encephalopathy
7.4.1 Minimal hepatic encephalopathy market estimates and forecasts, 2016 - 2027 (USD million)
7.5 Chemotherapy induced diarrhea
7.5.1 Chemotherapy induced diarrhea market estimates and forecasts, 2016 - 2027 (USD million)
7.6 Pathogen related infections
7.6.1 Pathogen related infections market estimates and forecasts, 2016 - 2027 (USD million)
7.7 Diabetic neuropathy
7.7.1 Diabetic neuropathy market estimates and forecasts, 2016 - 2027 (USD million)
7.8 ADHD
7.8.1 ADHD market estimates and forecasts, 2016 - 2027 (USD million)
7.9 Depression
7.9.1 Depression market estimates and forecasts, 2016 - 2027 (USD million)
7.10 Alzheimer’s disease
7.10.1 Alzheimer’s disease market estimates and forecasts, 2016 - 2027 (USD million)
7.11 Nutritional deficiency
7.11.1 Nutritional deficiency market estimates and forecasts, 2016 - 2027 (USD million)
7.12 Orphan diseases
7.12.1 Orphan diseases market estimates and forecasts, 2016 - 2027 (USD million)
7.12.2 Phenylketonuria
7.12.2.1 Phenylketonuria market estimates and forecasts, 2016 - 2027 (USD million)
7.12.3 Eosinophilic esophagitis
7.12.3.1 Eosinophilic esophagitis market estimates and forecasts, 2016 - 2027 (USD million)
7.12.4 FPIES
7.12.4.1 FPIES market estimates and forecasts, 2016 - 2027 (USD million)
7.12.5 Others
7.12.5.1 Others market estimates and forecasts, 2016 - 2027 (USD million)
7.13 Other applications
7.13.1 Other applications market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 8 Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Global Medical Foods Market: Sales Channel Market Share Analysis, 2019 and 2027
8.3 Online sales
8.3.1 Online sales market estimates and forecasts, 2016 - 2027 (USD million)
8.4 Institutional sales
8.4.1 Institutional sales market estimates and forecasts, 2016 - 2027 (USD million)
8.5 Retail sales
8.5.1 Retail sales market estimates and forecasts, 2016 - 2027 (USD million)

Chapter 9 Medical Foods Market: Regional Estimates & Trend Analysis, by Route of Administration, Product, Application, and Sales Channel
9.1 Global Medical Foods Market: Regional Movement Analysis
9.2 North America
9.2.1 Market estimates and forecasts by administration, Product, application, and sales channel, 2016 - 2027 (USD Million)
9.2.2 U.S.
9.2.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3 Europe
9.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3.2 U.K.
9.3.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3.3 Germany
9.3.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3.4 France
9.3.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3.5 Spain
9.3.5.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3.6 Italy
9.3.6.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.3.7 Russia
9.3.7.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4 Asia Pacific
9.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.2 China
9.4.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.3 Japan
9.4.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.4 India
9.4.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.5 Australia
9.4.5.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.6 New Zealand
9.4.6.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.7 Singapore
9.4.7.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.4.8 South Korea
9.4.8.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.5 Latin America
9.5.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.5.3 Mexico
9.5.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.5.4 Argentina
9.5.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.6 MEA
9.6.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.6.2 South Africa
9.6.2.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)
9.6.4 UAE
9.6.4.1 Market estimates and forecasts by administration, product, application, and sales channel, 2016 - 2027 (USD Million)

Chapter 10 Company Profiles
10.1 DANONE
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 NESTLÉ
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 ABBOTT
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 TARGETED MEDICAL PHARMA INC.
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 PRIMUS PHARMACEUTICALS, INC.
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 MEAD JOHNSON & COMPANY, LLC
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 FRESENIUS KABI AG
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 List of Other Companies


Note: Product cover images may vary from those shown
  • Danone
  • Nestlé
  • Abbott
  • Targeted Medical Pharma Inc.
  • Primus Pharmaceuticals, Inc.
  • Mead Johnson & Company, Llc
  • Fresenius Kabi Ag
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll